Fort Worth, TX, United States of America

Ralph P Stone

USPTO Granted Patents = 13 

Average Co-Inventor Count = 1.8

ph-index = 2

Forward Citations = 18(Granted Patents)


Location History:

  • Arlington, TX (US) (1996 - 1999)
  • Fort Worth, TX (US) (2016 - 2024)

Company Filing History:


Years Active: 1996-2024

Loading Chart...
13 patents (USPTO):

Title: The Innovations of Ralph P. Stone

Introduction

Ralph P. Stone, based in Fort Worth, TX, is an accomplished inventor with a remarkable portfolio of 13 patents. His work primarily focuses on advancements in ophthalmic formulations, targeting conditions such as dry eye and enhancing ocular health through innovative methods.

Latest Patents

One of Ralph's significant contributions is the patent for "Ophthalmic formulations and related methods." This invention addresses the need for effective treatments for dry eye and other ocular indications by providing long-lasting benefits. His research has led to methods aimed at increasing the thickness of the lipid layer, lubricating the eye, and maintaining the integrity of the tear film layers. These groundbreaking methods are critical in improving overall eye health and comfort.

Career Highlights

Ralph has made a significant impact in the field of ophthalmology through his work with notable companies. He has been associated with Eternatear, Inc. and Alcon Laboratories, Inc., where he has contributed his expertise to develop innovative pharmaceutical solutions. His prolific contributions to patent portfolios reflect his dedication to research and development in ocular treatments.

Collaborations

Throughout his career, Ralph has collaborated with esteemed colleagues, including Timothy R. Willis and Barry F. Van Duzee. These partnerships have been instrumental in furthering research and development efforts in the realm of ophthalmic science.

Conclusion

Ralph P. Stone stands out as a notable figure in the innovation landscape, particularly in the field of ophthalmic advancements. With a robust collection of patents and significant collaborations, his work continues to make a positive impact on eye care, benefiting patients and the medical community alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…